cefuroxime
Ceftin (cefuroxime axetil) is an oral second-generation cephalosporin antibiotic. It kills susceptible bacteria by disrupting their cell wall construction and is used for common infections of the throat, ears, sinuses, airways and urinary tract.
This page is based on FDA prescribing information and Health Canada product information for cefuroxime; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
A bacterium is constantly reinforcing its outer wall, like a crew laying bricks and mortar. Cefuroxime steals the trowel - it disables the enzymes that seal each new row - so the wall stays full of gaps, cannot hold the pressure inside, and collapses.
In simple terms
Bacteria are protected by a rigid cell wall that they must rebuild as they grow. Cefuroxime, a cephalosporin antibiotic, binds to the bacterial enzymes, called penicillin-binding proteins, that cross-link the wall material. With those enzymes out of action, the wall stays weak, holes form, and the bacterium breaks apart. Human cells do not build such a wall, so the drug attacks bacteria selectively.
In depth
Cefuroxime axetil is an oral prodrug hydrolysed to cefuroxime, a second-generation cephalosporin. Its beta-lactam ring acylates the active-site serine of penicillin-binding proteins, blocking peptidoglycan transpeptidation and triggering autolysin-mediated lysis. Compared with first-generation agents it has increased stability against some beta-lactamases and broader gram-negative coverage, while retaining activity against common gram-positive pathogens of the respiratory tract and skin.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
How cefuroxime axetil, a second-generation cephalosporin prodrug, works
- Cefuroxime steals the trowel - it disables the enzymes that seal each new row - so the wall stays full of gaps, cannot hold the pressure inside, and collapses.
- Cefuroxime axetil is an oral prodrug hydrolysed to cefuroxime, a second-generation cephalosporin.
- Its beta-lactam ring acylates the active-site serine of penicillin-binding proteins, blocking peptidoglycan transpeptidation and triggering autolysin-mediated lysis.
- Compared with first-generation agents it has increased stability against some beta-lactamases and broader gram-negative coverage, while retaining activity against common gram-positive pathogens of the respiratory tract and skin.
Target: Penicillin-binding proteins (PBPs)
Bacterial enzymes that stitch the final cross-links into the cell wall; when they are blocked, the wall weakens and the bacterium bursts.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- Pharyngitis and tonsillitis caused by susceptible bacteria, in adults and children
- Acute bacterial otitis media in pediatric patients
- Acute bacterial maxillary sinusitis in adults and children
- Acute bacterial exacerbations of chronic bronchitis in adults and children
Official sources
The statements on this page trace back to these records.
- U.S. Food and Drug Administration: cefuroxime axetil prescribing information
U.S. Food and Drug Administration
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.